✦
UWELL CLOUD YOU JIAN YUN

Pulmonary Nano-Mist Therapy

肺盾纳米雾

Inhalation devices deliver an aerosol to the respiratory tract. The adjective nano does not identify the medicine, effective delivery or a clinical indication. The formulation and delivery device must be evaluated together.

Historical anatomical illustration: lungs with branching bronchi and bronchioles · Historical anatomical illustration: entrance to the larynx seen from behind
Historical anatomical illustration · Image credits

Hospital named in the catalogue

Shulan (Boao) Hospital International Specialty Hospital
About this guide

Clinical details below are in English. Ask the care team for help understanding the source documents.

What to clarify

How assessment and planning work

For this catalogue entry, the next useful document is a specification covering: active ingredient, aerosol device and validated intended use. The receiving clinician should connect those details to the patient’s actual concern before suggesting tests, a schedule or travel.

Before your consultation

Full proposed formulation, device model, spirometry, respiratory diagnosis and inhaler list.

Send existing records for an initial discussion. Do not arrange new tests, change medication or book non-refundable travel solely from this page. The receiving team should state which additional information is actually needed.

Evidence and limitations

The material available for this named programme does not support a product-specific safety or effectiveness assessment. Possible interactions and procedure risks depend on what is actually supplied. A written product or protocol and the applicable clinical or research pathway are therefore required.

Questions to ask

What substance and device produce the proposed mist?

The word nano does not identify an active medicine or indication. Ask for the formulation, particle-delivery device and clinical objective, and whether it could interact with existing inhaled treatment.

What should be included in my written treatment plan?

The treating team should identify the proposed intervention, alternatives, relevant uncertainty, clinical eligibility, anticipated visits, monitoring and arrangements if the plan changes after assessment. Ask who is responsible for follow-up after you return home.

Price and quotation

Ask for an itemized provider quotation after the clinical team reviews your records. The scope may depend on the exact intervention, investigations, consumables, admission and monitoring. Confirm currency, validity period and what happens if the plan changes. Medical fees are paid directly to the provider; Uwell coordination is separate.

Reference catalogue

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Sariyah Ahmad
Active Triage Officer

Welcome to Uwell Cloud. Connecting from Malaysia, Indonesia, or Thailand? Ask me about visa-free travel and stem cell medical programs in Boao Lecheng.